articleJournal of Allergy and Clinical ImmunologySep 29, 2011BRONZE OA

Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

PGPhilippe GevaertNVNicholas Van BruaeneTCTom CattaertKVKristel Van SteenTVThibaut Van Zele

Ghent University · Age UK · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

621
total citations
FWCI
14.27
Percentile
100%
References
33
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Mepolizumab
  • Medicine
  • Placebo
  • Nasal polyps
  • Eosinophilia
  • Gastroenterology
  • Internal medicine
  • Interleukin 5
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding